welbournes

This Medicines Supply Notification supersedes the National Patient Safety Alert issued on 29 July 2025 Department of Health and Social Care (DHSC) has issued a medicine supply notification for Antimicrobial Agents Used in Tuberculosis (TB) Treatment MSN/2025/058 Tier 3 – high impact Date of issue: 23rd October 2025 Following the National Patient Safety Alert issued [...]

The post Medicine Supply Notification: Antimicrobial Agents Used in Tuberculosis (TB) Treatment appeared first on Community Pharmacy England.

The Department of Health and Social Care (DHSC) has today (23/10/2025) confirmed the following list of price concessions for October 2025: Drug Pack size Price concession Alfuzosin 2.5mg tablets 60 £6.85 Bumetanide 1mg tablets 28 £2.95 Buprenorphine 8mg sublingual tablets sugar free 7 £3.85 Clarithromycin 125mg/5ml oral suspension 70 £10.88 Clarithromycin 250mg/5ml oral suspension 70 £19.67 Duloxetine [...]

The post October 2025 Price Concessions 2nd Update appeared first on Community Pharmacy England.

MHRA Class 3 Medicines Recall: Ipratropium Bromide 500 microgram / 2ml Nebuliser Solution (Accord Healthcare Ltd) Drug Alert Number: EL(25)A/45 Date issued: 23 October 2025 Accord Healthcare Ltd is recalling a batch of Ipratropium Bromide 500 microgram/2ml Nebuliser Solution after a foil pouch was found to contain ampoules with incorrect labels intended for the Korean market. [...]

The post MHRA Class 3 Medicines Recall: Ipratropium Bromide 500 microgram / 2ml Nebuliser Solution (Accord Healthcare Ltd) appeared first on Community Pharmacy England.

Department of Health and Social Care (DHSC) has issued a medicine supply notification for Amiodarone 100mg and 200mg tablets MSN/2025/056 Tier 2 – medium impact Date of issue: 20th May 2025 Amiodarone 100mg and 200mg tablets are in limited supply until w/c 17 November 2025 Amiodarone suspension remains available (Specials). Unlicensed imports of amiodarone 100mg [...]

The post Medicine Supply Notification: Amiodarone 100mg and 200mg tablets appeared first on Community Pharmacy England.

The Department of Health and Social Care (DHSC) has issued a medicine supply notification for the following products: Mometasone (Asmanex Twisthaler®) 200micrograms/dose dry powder and 400micrograms/dose dry powder inhalers MSN/2025/057 Tier 2 – medium impact Date of issue: 20/10/2025 Mometasone (Asmanex Twisthaler®) 200microgram/dose dry powder inhaler (60 dose) is being discontinued from late October 2025. [...]

The post Medicine Supply Notification: Mometasone (Asmanex Twisthaler®) 200micrograms/dose dry powder and 400micrograms/dose dry powder inhalers appeared first on Community Pharmacy England.